48 related articles for article (PubMed ID: 11761450)
41. Transmembrane domain (TM) 9 represents a novel site in P-glycoprotein that affects drug resistance and cooperates with TM6 to mediate [125I]iodoarylazidoprazosin labeling.
Song J; Melera PW
Mol Pharmacol; 2001 Aug; 60(2):254-61. PubMed ID: 11455011
[TBL] [Abstract][Full Text] [Related]
42. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.
Dey S; Hafkemeyer P; Pastan I; Gottesman MM
Biochemistry; 1999 May; 38(20):6630-9. PubMed ID: 10350482
[TBL] [Abstract][Full Text] [Related]
43. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
44. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
Wang Y; Georges E
Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
[TBL] [Abstract][Full Text] [Related]
45. Mutations in the sixth transmembrane domain of P-glycoprotein that alter the pattern of cross-resistance also alter sensitivity to cyclosporin A reversal.
Ma JF; Grant G; Melera PW
Mol Pharmacol; 1997 Jun; 51(6):922-30. PubMed ID: 9187258
[TBL] [Abstract][Full Text] [Related]
46. Further characterization of the sixth transmembrane domain of Pgp1 by site-directed mutagenesis.
Song J; Melera PW
Cancer Chemother Pharmacol; 2001 Nov; 48(5):339-46. PubMed ID: 11761450
[TBL] [Abstract][Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
